Facilitated By

San Antonio Medical Foundation

Efficacy study of mAb therapeutic against EBOV lethal challenge in rhesus macaques qRT PCR

Texas Biomedical Research Institute

 

As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.

Principal Investigator(s)
Carrion, Ricardo
Funded by
Regeneron Pharmaceuticals, Inc.
Research Start Date
Status
Active

The goal of this research project is to perform Ebola infected PK/PD qPCR analysis for the efficacy study of mAb therapeutic against EBOV lethal challenge in rhesus macaques.

Collaborative Project
Basic Research
Infectious Disease